An capability to attract a distinction between an importer and wholesaler of medical cannabis is important to the understanding of the German distribution market, says Jakob Sons, co-founder of Frankfurt-based Cansativa.
Not all distributors of medical cannabis in Germany have the identical varieties of licenses, he famous in an e mail to Marijuana Business Daily.
“If we are talking about intra-European Union trade, the correct term is ‘wholesale.’ A company that holds a wholesale distribution authorization and a Good distribution practice (GDP) certificate is not allowed to ‘import’ products originating from outside the European Union,” Sons defined.
In different phrases: According to German legislation, “import” refers to importing merchandise from exterior the European Union.
Cansativa stated June 26 it obtained “a 7-digit loan financing at an annual interest rate of 1.2% with a term of six years.”
The firm will use the cash to “further increase inventory, working capital and to invest in tangible fixed assets.”
Cansativa provides German pharmacies completely different manufacturers of medical cannabis.
In addition to having flower sourced from the Netherlands, the Cansativa portfolio consists of merchandise that it buys from the German subsidiaries of Canadian producers Aurora Cannabis, Canopy Growth and Tilray.
Sons defined the corporate’s technique of having a “multibrand medical cannabis portfolio,” arguing that being a “one-stop shop” differentiates the agency from rivals.
“Instead of reaching out to many different suppliers, pharmacists can purchase medical cannabis at the centralized Cansativa platform,” he stated.
“Besides our broad portfolio, we differentiate from competitors with our top-notch medical cannabis-specialized sales team and several industry-leading service levels like delivery times.”
Cansativa operates its personal narcotics vault, not like different distributors that use third-party service suppliers to retailer and distribute the medicines.
Earlier this month, MJBizDaily visited Cansativa’s facility close to Frankfurt, Germany, for a behind-the-scenes tour of how the corporate runs.
In the next video interview, Cansativa co-founders Jakob and Benedikt Sons clarify the variations among the many major licenses and permits related for importers and distributors of medical cannabis in Germany.
The brothers talk about the:
- Medicinal Products Act (“Arzneimittelgesetz,” AMG).
- Narcotic Drugs Act (“Betäubungsmittelgesetz,” BtMG).
- Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP).
- Permits wanted to distribute irradiated medicines, recognized in Germany as “AMRadV.”
The video interview consists of unique entry and authentic footage of the vault, exhibiting how the Cansativa co-founders course of an precise pharmacy order.